Barro, Christian, Allexya A. M. Affonso, Ahmed Waquar, Natalia Aragao, Ali Bakheet, Karen Cajiao, Alexandre B. C. Souza, Luis A. Q. Díaz, Carolyn M. Fowler, Renata Herrera, Luis A. N. Huapaya, Kira Kornienko, Andressa M. V. Magalhães, Tiago d. O. Menezes, María-Alicia Mordojovich, Ricardo Nosé, Hua Pan, Karoline S. Persivale, Claudia Poveda, Clara Ramos, Maria A. Rodrigues, José M. V. Ruiz, Rafael Soares, and Xu DangHan. “The INCA Trial: A Multicenter, Randomized, Phase II, Open-Label Clinical Trial to Evaluate the Combination Therapy With Ipilimumab Plus Nivolumab Versus Chemotherapy (Pemetrexate-Cisplatin) in Patients With Advanced Non-Squamous NSCLC Naive to Treatment”. Principles and Practice of Clinical Research 4, no. 1 (July 25, 2018): 6-13. Accessed August 14, 2020. https://journal.ppcr.org/index.php/ppcrjournal/article/view/62.